Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MedCognetics
AddedFeb 18, 2024
UpdatedJun 18, 2026
MedCognetics

MedCognetics

Pre-Seed

Medcognetics: An AI platform enhancing radiology workflow for early, efficient breast cancer detection.

HQ
Dallas, TX, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

MedCognetics, founded with a mission to revolutionize radiology through artificial intelligence, focuses on enhancing the efficiency and accuracy of breast cancer detection. Their AI-based platform empowers radiologists by prioritizing mammograms flagged as suspicious, thereby improving workflow and reducing burnout. The company's vision is to reduce breast cancer mortality by enabling early detection and addressing radiologist shortages, particularly in underserved regions.

Notable figures associated with MedCognetics include experts in AI and healthcare, although specific names are not provided. The company has garnered attention for its innovative approach to managing radiologist workloads and improving patient outcomes. By leveraging global collaboration, MedCognetics has made significant strides in transforming healthcare, demonstrating a substantial impact on both radiologists' efficiency and patient care quality.

MedCognetics - Similar Companies

RAD AI logo

RAD AI

radai.com

CognitiveCare logo

CognitiveCare

cognitivecare.com

ChestAi logo

ChestAi

DeepRadiology logo

DeepRadiology

deepradiology.com

AI Metrics logo

AI Metrics

aimetrics.com

Arctic Fox AI logo

Arctic Fox AI

afxmedical.com

Remedy Logic logo

Remedy Logic

remedylogic.com

Biocogniv logo

Biocogniv

Nulogix Health logo

Nulogix Health

deephealth.com

RadLogics logo

RadLogics

radlogics.com

Braid Health logo

Braid Health

braid.health

Regard logo

Regard

withregard.com

meMR Health logo

meMR Health

MedRank logo

MedRank

Medgeo logo

Medgeo

medgeo.com

MedCognetics - Quick Facts

Who are MedCognetics' competitors?

Companies similar to MedCognetics include RAD AI, CognitiveCare, ChestAi and DeepRadiology.

When was MedCognetics founded?

MedCognetics was founded in 2020.

Where is MedCognetics' headquarters located?

MedCognetics' headquarters is located in Dallas, TX, US.

When was MedCognetics' last funding round?

MedCognetics' most recent funding round was for $750k (USD) in January 2023.

How much has MedCognetics raised to-date?

As of Jan 26, 2023, MedCognetics has raised a total of $750k (USD).

How many employees does MedCognetics have?

MedCognetics has 7 employees as of Feb 4, 2024.

MedCognetics - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • AI Platform
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 8 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 620000Health Care and Social Assistance
SIC
  • 8060Hospitals
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified